Not exact matches
Ongoing studies at Uppsala University in Sweden have shown that the chemical agent dubbed Pittsburgh Compound - B, or PIB, is a highly accurate
marker of plaque buildup and that its abundance in the brain can predict whether patients with mild
cognitive impairment will develop Alzheimer's — and when that
decline will likely start.
A better understanding
of the neural determinants
of changes in fluid intelligence is therefore necessary for improving our understanding
of healthy
cognitive aging, and may aid the development
of early
markers for individuals at risk
of rapid
decline.
Each
of these
markers of chronic inflammation has been linked to a wide range
of conditions including heart disease, osteoporosis,
cognitive decline and Alzheimer's, and type - 2 diabetes.